Topics

FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma

13:01 EST 23 Jan 2020 | Drugs.com

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 23, 2020-- Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...

Original Article: FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma"

Quick Search

Relevant Topic

Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them. ...